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807-5 A Multicenter Study of the Safety and Efficacy of 
Disopyramide for Treating Symptomatic Obstructive 
Hypertrophic Cardiomyopathy 
Mark Sherrid Ivan Barac, Barry Maron, Susan Casey, Lidia Chojnowska, Shaughan -1 
Dickie, Perry Elliott, William McKenna, St. Luke’sRoosevelt Hospital Center, New York 
City, NY 
Background: Disopyramide (diso) has been shown to reduce gradient and improve 
symptoms in patients (pts) with obstructive hyperlrophic cardiomyopathy (HCM). It is 
often administered to medically refractory pts who would otherwise next require septal 
myectomy or other interventions. However, the clinical course of HCM pts treated with 
diso has never been investigated in a large cohort. Methods: 141 pts with HCM were 
treated with diso at 4 treatment centers from 1990 to 1999. Resting echo gradient and 
NYHA class were compared before diso and at follow-up on medication. Results: 141 
pts (mean age 46.6) were treated with diso for a mean of 3.9 years with a mean highest 
dose of 426 + 180 mg/day. Most recent gradient on diso was 45 + 34 mm Hg, signifi- 
cantly lower than baseline gradient 78 -+ 35 mm Hg, a 42% reduction, p>O.OOOl. 74% of 
pts had > 15 mm Hg reduction in gradient, and 42% had > 40% reduction. NYHA class 
improved on drug, 16165/28/Z to 36/57/18/O for classes I, II, Ill, IV respectively, p>O.Ol. 
Also, the percentage of patients in NYHA class Ill and IV decreased after diso from 27% 
to 16%, p=O.O5. There were 4 HCM-related sudden cardiac deaths that occurred on diso, 
occurring mean 54 months after initial administration of diso. Annual rate of HCM-related 
sudden cardiac death was 0.88% and annual rate of all-cause cardiac death was 1.29%. 
Mortality on diso did not differ from that in 5 separate published series of HCM pts each 
with a250 patients published from 1998-2001 where annual rate of sudden cardiac death 
ranged from 0.74-1.13%, ~~0.47 and annual rate of all-cause cardiac death. ranged from 
1.22-I .78%. p=O.l8. 93 pts (88%) were still on diso at follow-up. The majority of pts could 
be managed without myectomy or other intervention; but, while taking diso 32% ulti- 
mately required intervention for relief of obstruction. Conclusions: Patients with HCM 
treated with disopyramide showed a significant and persistent decrease in outilow gradi- 
ent of 42% and improvement in limiting symptoms. No excess sudden cardiac death 
occurred. A therapeutic trial of disopyramide should be considered before proceeding to 
major intervention in obstructive HCM. 
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809-l Early Postinfarction Ventricular Restraint Prevents 
Adverse Remodeling and Preserves Borderzone 
Contractile Function 
Beniamin M. Jackson, Joseph H. German, Ill, Sina L. Moainie, Navneet Narula, Jagat 
Narula, Martin G. St. John Sutton, L. H. Edmunds, Jr., Robert C. German, Hospital of the 
University of Pennsylvania, Philadelphia, PA, Hahnemann University Hospital, 
Philadelphia, PA 
Background: Postinfarction ventricular remodeling is the major cause of CHF. Early inf- 
arct expansion (stretching) initiates adverse remodeling and progressive contractile dys- 
function in normally-perfused borderzone (BZ) myocardium. Early LV restraint may 
prevent this maladaptive phenomenon. 
Methods: An infarction of 20% of the LV mass known to cause CHF and LV dilatation in 
8 weeks was performed in 12 sheep. In six sheep Merselme mash was wrapped around 
the exposed LV (excluding septum and RV) at the time of infarction. Six sheep acted as 
controls. LV remodeling, diastolic function, regional contractility and perfusion were 
assessed by echocardiography, sonomicrometry and microsphere injections, respec- 
tively, over 8 weeks. 
m: The control group experienced progressive LV dilatation, expansion of the aki- 
netic segment and progressive borderzone contractile dysfunction. Infarct expansion, LV 
dilatation and borderzone contractile dysfunction were prevented or significantly reduced 
in the animals having early postinfarction LV wrapping. Myocardial perfusion was 
unchanged in the uninfarcted regions in all animals. There was no evidence of wrap- 
induced diastolic dysfunction. 
Conclusion : Early postinfarction ventricular restraint to prevent infarct expansion pre- 
vents adverse remodelino and preserves contractile function in non-infarcted myocar- 
dium. 
(^ pcO.05 preinfarct vs. postinfarct, 
mined immediately after infarction) 
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809-2 Matrix Metalloproteinase Inhibition In Transgenic Mice 
With Modified Cardiac Restricted Tumor Necrosis 
Factor Expression: Effects on Lefl Ventricular 
Geometry and Function 
Abhinav Diwan, Eric M. Wilson, Andrea M. Parkhurst, Patricia Escobar, Jennifer W. 
Hendrik, Kathryn B. Dowdy, Abigail S. Lowry, Jennifer R. Holder, Dorellyn Lee-Jackson, 
Francis G. Spinale, Douglas L. Mann, Baylor College of Medicine, Houston. TX, Medical 
University of South Carolina, Charleston, SC 
Background: Matrix metalloproteinases contribute to adverse left ventricular (LV) 
remodeling and are influenced by tumor necrosis factor (TNF) signaling: however, a 
causal relationship remains to be established. We examined the effects of matrix metal- 
loprotelnase inhibition (MMPi) on LV geometry and function in 2 lines of transgenic mice 
with myocardial overexpression of (I) secreted TNF (sTNF) that develop LV dilation, (2) 
a non-cleavable membrane bound form of TNF (mTNF), that develop concentric LV 
hypertrophy. 
Methods: MMPi (PD166793 30mg/kg/day) was instituted from 3 to 6 weeks of age in 
sTNF (n=l3) and mTNF (n=7) mice. Untreated 6 week old wild type (n=l3), sTNF (n=ll) 
and mTNF (n=8) mice served as conlrols. LV end-diastolic volume and ejection fraction 
were determined by conductance volumetry and contractility assessed by computing 
E,,, with caval occlusion. 
Results: (Table: ‘peO.05 vs wild type, tvs mTNF, #vs sTNF). LV end-diastolic volume 
was increased in the sTNF group and was reduced with MMPi. MMPi increased LV ejec- 
tion fraction in both the sTNF and mTNF groups, likely due in part to increased E,,,. LV 
hypertrophy was unaffected by MMPi. 
Conclusions: MMPi reduced the amount of LV dilation in the sTNF mice, suggesting 
that MMP-induced alterations in the extracellular matrix influence myocardial structure 
(dilation). MMPi resulted in an increase in contractile function in fhe mTNF and sTNF 
mice, suggesting that MMP-induced alterations in the extracellular matrix influence myo- 
cardial function. 
Results : All values are Mean * SEM 
Wild mTNF mTNF+M sTNF sTNF+M 
Type MPi MPi 
End-Diastolic Volume (pL) 39*2 42~4 36*3 81+4’ 49*4’# 
t 
Ejection Fraction (%) 66*1 66*2 73il *t 68*2 7l+l’t 
E,,,,, (Maximal Chamber Elasticity, 5.3i0.8 5.1~1. 11.3*1.4” 5.3+1. 10.4*2.2’ 
mmHg/@) 3 t 3 # 
LV Mass/Tibia (mg/mm) 5.8kO.3 8.2+0. 8.3eO.4 8.6&O. 7.8eO.5’ 
3’ 3 
9:45 a.m. 
809-3 Testosterone Aggravates Cardiac Performance and 
Remodeling in Mice After Myocardial Infarction 
Maria A. Cavasin, Ai-Li Yu, Shreevidya Menon, Xiao-Ping Yang, Henry Ford Health 
System, Detroit, MI 
The cardioprotective effects of estrogen have been widely studied. However, little is 
known about the effects of testosterone (T) on chronic remodeling and prognosis after 
Ml. We found that female mice given supplemental T had significantly higher mortality 
(due lo cardiac rupture) than those treated with placebo (P) during the first week after Ml 
regardless of ovariectomy. whereas castration significantly reduced mortality in males. 
We hypothesized that testosterone may aggravate chronic cardiac remodeling and dys- 
function, whereas estrogen may be cardioprotective after Ml. 4.week-old males and 
females underwent either castration (cas), or sham castration (s-cas), and ovariectomy 
(ovx) or sham ovariectomy (s-ovx). respectevely. S-ovx females were treated with either 
JACC March 19,2003 ABSTRACTS - Cardiac Function and Heart Failure 171A 
P or T. MI was induced 6 weeks later. Echocardiography was performed in awake mice 
before and after MI monthly for 3 months and myocyte cross-sectional area (MCSA) was 
measured at the end of the study. In females, T or ovx further decreased ejection fraction 
(EF), but only T significantly increased LV dimensions (LVD) and MCSA compared to the 
s-ovx+P group (Table). In males, castration significantly improved EF and prevented 
myocyte hypertrophy. Our data suggest that testosterone aggravates LV dysfunction and 
remodeling in mice after MI. whereas estrogen only prevents deterioration of LV perfor- 
mance but does not have much Impact on structural remodeling. Table shows values at 
12 weeks after Ml. f p&O1 vs Ml+s-ovx+P. - p < 0.05 “s Ml+s-cas 
Ml+s-ovx+P Ml+s-ovx+T Ml+ovx Ml+s-cas Ml+cas 
EF (%) 49.8t3.2 33.0*1.9f 34.9+3.7f 35.9zt2.5 46.6k4.3’ 
LVDd(mm) 3.6eO.2 4.2zto.22: 3.9+0.3 3.9+ 0.3 3.7iO.2 
MCSA(um2) 273+15 375+32f 295*19 317*11 281*16 
IO:00 a.m. 
809-4 Biological Ex-Viva Pre Differentiation of Adult Bone 
Marrow-Derived Mesenchymal Stem Cells for Cardiac 
Repair in a Chronic Dog Model of Myocardial Infarction 
Jozef Bartunek, Jeffrey D. Croissant. Jeannie G. Liu, Ike W. Lee, Bernard De Bruyne, 
William Wijns, Martin Penicka, Marc Vanderheyden, Bernard Gerber, Jean-Louis J. 
Vanoverschelde, Guy R. Heyndrickx, OLV-Hospital, Aalst, Belgium, Anterogen Co., 
Boston, MA 
Background. The in viva cardiac differentiation of adult bone marrow mesenchymal 
stem cells (BMSCs) after myocardial infarction (Ml) is controversial. It was hypothesized 
that pretreatment of BMSCs may facilitate their commitment towards the cardiac differen- 
tion in vim. Accordingly, we investigated the feasibility of ex viva pre-dlflerentiation of the 
BMSCs using the biological growth factors and their potential to undergo engraftment 
and further cardiac differentiation in viva in a model of chronic Ml. Methods. We used a 
chronic dog Ml model due to ligation of the circumflex coronary artery (n = 12). Four 
weeks after the ligation, the presence of regional dysfunction was confirmed by echocar- 
diography. Then, BMSCs were culture expanded and differentiated into procardiac lin- 
eage (identified by the presence of the Nkx 2.5 homeobox gene) by @ding the biological 
growth factors, mainly bFGF. Modified cells were labelled with Dil andfrozen until directly 
injected to the infarcted myccardium > 8 wks after the Ml. Results. Injected BMSCs were 
identified in the Ml area. At various injection sites, the further cardiac differentiation was 
confirmed by colccalization of cardiac myosin in Dil positive cells as early as 2 wks after 
injections. Furthermore, the Dil-cardiac mywn positive cells were morphologically 
aligned with neighborlng myocardial cells. In addition, functional analysis at 4 wks after 
injection (n=4. 60.250 x 10s cells) showed a trend to an increase in fractional and area 
shortening (262 4 vs 29+ 3%; pzO.059 and 48+ 10 vs 53r 6%; p=O.O54. respectively). 
Conclusions. Present data demonstrate for the first time that ex viva biologically predif- 
ferentiated autologous adult BMSCs can be incorporated into the infracted myocardium. 
These cells appear to undergo further cardiac differentiation that may be associated with 
functional improvement of the dysfunctional myocardium. 
IO:15 a.m 
809-5 The Effects of Tumor Necrosis Factor, Angiotensin, and 
Phenylephrine on Myocyte lntegrin lsoform Transition 
and Cytoskeletal Rearrangement: A Clue to Post-Infarct 
Remodeling 
Mei Sun Pu Llao, Thomas Parker, Peter LIU, University of Toronto, Toronto, ON, -3 
Canada, Toronto General Hospital, Toronto, ON, Canada 
Background: lntegrins are important cell-surface molecules that link the extracellular 
matrix (ECM) to the cellular cytoskeleton. We have previously shown that the myocardial 
expression of the dominant cytoskeletal in&grin l31D was decreased in post-infarct 
remodeling. To elucidate its mechanism. we studied the effect of tumor necrosis factors 
(TNF), anglotensln II (Angll) and phenylephrine (PE) on in&grin 01 and associated 
cyioskeletal signals in cardiomyocytes. Methods: Neonatal rat ventricle myocytes were 
isolated from ventricles of l- to P-day-old Sprague-Dawley rats. The myocytes were cul- 
tured on laminin-coated cover slips in serum-free medium. The medium of treatment 
groups respectively contains 30nglml TNF, 100 mmol/L Angll and 100 mmol/L PE. The 
treatment lasted 24 hours. The effects of the TNF, Angll and PE on myocyies were 
examined by RT-PCR, western blot, and immunofluorescence staining. Experiments 
were repeated also on adult cardiomywytes similarly isolated from IO week old rat 
hearts. Resufts: The results showed that TNF-a significantly decreased BlD expression 
at mRNA level in cardiomyocyies, PE increased, while Ang II didn’t affect i&grin BID 
expression. lmmunofluorescence staining and Western Blot showed a significantly 
decreased density of a-actinin, disorganization of psxillin and decreased expression of 
focal adhesion ktnase (FAK). However, exposure to PE and Angll induced an increased 
expression of a-actinln, pexillin and FAK in neonatal cardiac myocytes. The striation pat- 
ter of paxillin showed increase in the size of the punctate regions. Neonatal cardiac myo- 
cytes were more susceptible to TNF-a treatment than the adult cardvx myocytes. 
Conclusions: These results suggest that TNF is the ms]or local factor that down regu- 
lates in&grin l3lD expression, decrease a-actinin, paxillin and reduce FAK activities, 
accounting for the phenotype observed in post Ml remodeling. All and PE changes are 
more associated with hypertrophy. linking key neurohumoral changes with events asso- 
ciated with cytoskeletal remodeling. 
ORAL CONTRIBUTIONS 
816 Myocarditis 
Monday, March 31, 2003, 11:OO a.m.-12:15 p.m. 
McCormick Place, Room S402 
1 l:oo a.m. 
816-l Effects of Momordicin on Experimental Murine 
Coxsackievirus B, Myocarditis 
Shuanaiie Li Zuo Wang, Ying Zhen Yang, Congfeng Xu, Zhao Cai Zhang, Liping Bu, 
Yukun Luo. Chengxing Shen, Junbo Ge, Shanghai Institute of Cardiovascular Disease, 
Zhongshan Hospital, Shanghai, People’s Republic of China 
Background Viral myocarditis is an inflammatory heart disease caused by cardiotropic 
virus infection and the reliable and effective therapy is lacking. Momordicin, an active 
compound from juice of Momordica charantin L, was reported to have antiviral effect. We 
tested if this compound could be an effective therapy for viral myocarditis induced by 
coxsackievirus 4 (CVB$ in a munne model. 
Methods Four-weeks-old BALBIC mice were inoculated with Nancy strain of CVB,. 
Momordicin(GOmg.kg’ .d”, group A; 20mg.kg-‘.d-‘ , group B and 5mg.kg-’ .d’ , group C, 
respectirely) was administered once daily, starting on day 0 to day 6. and control mice 
received vehicle. Survival rates were determined on day 14, myocardial histopathology 
on day 7 and 14 respectively, the myocardial virus concentration, CVBs-RNA levels 
(semiquantitative RT-PCR) and cardiomyocyte apotosis (CA, TUNEL method) on day 7. 
Results: The survival rate on day 14 was significantly improved in mice treated with 
momordicin (100%’ in group A , 89%’ in group B, 68%’ in group C) than that of control 
group (43%, pcO.05 vs. control group, n=l5 in each group). Momordicin treatment also 
significantly attenuated histological myocardial lesion, reduced the myocardial virus con- 
centration (lgTCID& [i .OE eO.47’ in group A, 1.43*0.69’ I” group B, 2.15*0.56’ in group 
C] than that in the control group (2.91*0.50, n=lO in each group) and CV&-RNA levels 
[0.26+0.58’ in group A, 0.39iO.74’ in group B.O.97+0.66” in group C] than that in the 
control group (1.47iO.62, n=8 in each group). Reduced amount of CA (0.13+0.04%’ in 
group A, 0.16&08%’ in group 8,0.25+0.06%’ in group C) were found in the treatment 
group than that of control group (0.38+0.09%, n=8 in each group) Conclusion: The 
results showed that early momordicin therapy improved survival, reduced myocardial 
necrosis and apoptosis in this model dose-dependently. Inhibiting virus replication in 
myocardium could be one of the mechanisms for its beneficial effect since the myocardial 
viral content and CVBs-RNA levels were reduced after treatment. Our findings also sug- 
gest the importance of direct viral effect in cardiomyocyte damage by both apoptosis and 
necrosis in CVB, myocarditis. 
11:15 a.m. 
816-2 Relevance of Heat Shock Protein 60 in Human 
Myocarditis 
Silvia Lentini Silvia DO,, Karin Klingel, Reinhard Kandolf, Berndt LOderitz, Gerhard 
Bauriedel, Heart Center University of Bonn, Bonn, Germany. Institute of Molecular 
Pathology, Tiibingen, Germany 
Purpose: Heat shock proteins (HSP) act as endogenous cellular protectors in response 
to injury. A pathogenic role by antigenic mimicry with microbial antigens is currently dis- 
cussed. The aim of our study was to determine the role of HSPGO in myocarditis under 
consideration of viral infection, especially with Parvovirus Bl9 (PVBIS). 
Methods: A total of 93 left ventricular endomyocardial biopsies were retrieved from 
patients with cardiac dysfunction and classified histopathologicatly into myocarditis 
(n=41), dilated (DCM, n=26) and hypertrophic cardiomyopathy (HCM, n=l6). No histo- 
pathologlcal abnormalities were found in IO cases. Viral genome was analyzed by PCR 
for PVEIS, Epstein-Barr (EBV), Enterovirus (EV) and Human Herpes Virus 6 (HHVG). 
Apoptosis was detected by TUNEL, HSPGO by immunohistochemistry. EDV, its index 
EDVI and EF were assessed by ventriculography. 
Results: As to mywarditis PVBIS DNA was found in 58%. EV DNA in 5%, EBV DNA in 
7%, HHV6 DNA in co-infection with PVBIS in 2%, whereas in 34% no virus was detected 
by PCR. PVBl9 myocarditis was associated with a lower EF than virus negative myo- 
carditis (40+/-15% vs 52+1-15%, p=O.O45) at time of biopsy, while there were no differ- 
ences in EDV or EDVI. Myocyte (MC) and Interstitial cell (IC) density were similar in both 
groups (p=O.O8), whereby a positwe correlation between MC density and EF could be 
found (p&lt;O.OOl, p=O.O24). HSPGO expressron in MC and IC were higher an virus nega- 
tive than in PVB19 myocarditis (18.0+/- 16.9% vs 1.5 +/-2.4%, p=O.O05; 12.4+/-10.1 vs 
2.5+/-5.0%, p=O.O02). In virus negative myocarditis HSPGO expression correlated 
inversely with the EF (r=-0.68. p=O.O14) and with the MC density (w0.69, p=O.Ol). No 
relationship was found between HSP 60 expression and EDV or EDVI. Apoptotic indices 
showed no difference between the both groups and no correlation wth HSPGO expres- 
sion or hemodynamics. 
Conclusions: HSPGO expression correlates inversely with the myocyte density and the 
EF in virus negative myocarditis, whereas HSPGO expression is significantly decreased 
in PVB19 myocarditis. The differential role of HSPGO for virus negative and PVB19 myo- 
carditis in the progression of heart failure merits further investigation. 
